# FDA 483 - Lisa S. Wang, M.D. - October 13, 2023

Source: https://www.keypedia.com/records/483/lisa-s-wang-md/f02148f2-ea09-424a-9aab-a6dc5a8f3dd3

> FDA 483 for Lisa S. Wang, M.D. on October 13, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Lisa S. Wang, M.D.
- Inspection Date: 2023-10-13
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of Lisa S. Wang, M.D., a clinical investigator in Whittier, CA, revealed significant deficiencies in the conduct of clinical investigations. The firm failed to report a serious adverse event to the sponsor within the required 24-hour timeframe as per protocol. Additionally, the inspection found a failure to maintain adequate and accurate case histories, with numerous discrepancies identified between various source documents for adverse events.

## Related Officers

- [Grace P. Santos](https://www.keypedia.com/people/grace-p-santos/6f7d8c5d-2044-437b-ac04-a4d63d8a2c5e)
- [investigator](https://www.keypedia.com/people/cheron-m-portee/c2cf139d-e4ce-400d-893e-bd733b3ec3a9)
- [Jasmine Y. Wang](https://www.keypedia.com/people/jasmine-y-wang/e23c7335-477c-4671-8dcc-72e9149d424e)

Company: https://www.keypedia.com/companies/lisa-s-wang-md/6c75221d-b411-4753-a7d3-877edd39e749

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6